MyRisk TestSALT LAKE CITY, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced MyRisk® Hereditary ...

Myriad Genetics’ third quarter saw revenue and adjusted profit in line with Wall Street expectations, but the market reacted ...

The initiative ensures veterans of the Armed Services will have access to comprehensive pharmacogenomic and germline genetic ...

Genetic testing has had a shift in the past ten years, as it has left medical laboratories and entered living rooms.

With more than 250 peer-reviewed papers published in several high-impact journals, Katalin Susztak, MD, PhD, has opened the ...

In the largest genetic analysis of polycystic ovary syndrome to date, scientists have identified new variants linked to the ...

Research on Tourette’s indicates that the condition is strongly influenced by inherited genetic factors, with environmental factors also contributing to its development. Tourette syndrome is a ...

What we choose to study—whether fine art or finance—is one of the most influential decisions in our lives. It shapes not only ...

The earnings call highlighted a decline in Anatomic Pathology revenue by $2.1 million (7.6% sequentially) due to timing of collections. However, there was a year-over-year increase of $1.8 million ...